320 related articles for article (PubMed ID: 8062415)
1. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
2. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocyte mechanics in transgenic mice.
Kadambi VJ; Ponniah S; Harrer JM; Hoit BD; Dorn GW; Walsh RA; Kranias EG
J Clin Invest; 1996 Jan; 97(2):533-9. PubMed ID: 8567978
[TBL] [Abstract][Full Text] [Related]
3. Targeted overexpression of phospholamban to mouse atrium depresses Ca2+ transport and contractility.
Neumann J; Boknik P; DePaoli-Roach AA; Field LJ; Rockman HA; Kobayashi YM; Kelley JS; Jones LR
J Mol Cell Cardiol; 1998 Oct; 30(10):1991-2002. PubMed ID: 9799653
[TBL] [Abstract][Full Text] [Related]
4. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
5. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
[TBL] [Abstract][Full Text] [Related]
6. Monomeric phospholamban overexpression in transgenic mouse hearts.
Chu G; Dorn GW; Luo W; Harrer JM; Kadambi VJ; Walsh RA; Kranias EG
Circ Res; 1997 Oct; 81(4):485-92. PubMed ID: 9314829
[TBL] [Abstract][Full Text] [Related]
7. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility.
Koss KL; Grupp IL; Kranias EG
Basic Res Cardiol; 1997; 92 Suppl 1():17-24. PubMed ID: 9202840
[TBL] [Abstract][Full Text] [Related]
8. Phospholamban gene dosage effects in the mammalian heart.
Luo W; Wolska BM; Grupp IL; Harrer JM; Haghighi K; Ferguson DG; Slack JP; Grupp G; Doetschman T; Solaro RJ; Kranias EG
Circ Res; 1996 May; 78(5):839-47. PubMed ID: 8620604
[TBL] [Abstract][Full Text] [Related]
9. Phospholamban ablation and compensatory responses in the mammalian heart.
Chu G; Ferguson DG; Edes I; Kiss E; Sato Y; Kranias EG
Ann N Y Acad Sci; 1998 Sep; 853():49-62. PubMed ID: 10603936
[TBL] [Abstract][Full Text] [Related]
10. Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.
Brittsan AG; Ginsburg KS; Chu G; Yatani A; Wolska BM; Schmidt AG; Asahi M; MacLennan DH; Bers DM; Kranias EG
Circ Res; 2003 Apr; 92(7):769-76. PubMed ID: 12637367
[TBL] [Abstract][Full Text] [Related]
11. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo.
Zhai J; Schmidt AG; Hoit BD; Kimura Y; MacLennan DH; Kranias EG
J Biol Chem; 2000 Apr; 275(14):10538-44. PubMed ID: 10744747
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Kiss E; Brittsan AG; Edes I; Grupp IL; Grupp G; Kranias EG
Circ Res; 1998 Sep; 83(6):608-13. PubMed ID: 9742056
[TBL] [Abstract][Full Text] [Related]
13. Altered phospholamban-calcium ATPase interaction in cardiac sarcoplasmic reticulum during the progression of sepsis.
Wu LL; Tang C; Dong LW; Liu MS
Shock; 2002 May; 17(5):389-93. PubMed ID: 12022759
[TBL] [Abstract][Full Text] [Related]
14. Replacement of the muscle-specific sarcoplasmic reticulum Ca(2+)-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart.
Ver Heyen M; Heymans S; Antoons G; Reed T; Periasamy M; Awede B; Lebacq J; Vangheluwe P; Dewerchin M; Collen D; Sipido K; Carmeliet P; Wuytack F
Circ Res; 2001 Oct; 89(9):838-46. PubMed ID: 11679415
[TBL] [Abstract][Full Text] [Related]
15. Mouse phospholamban gene expression during development in vivo and in vitro.
Ganim JR; Luo W; Ponniah S; Grupp I; Kim HW; Ferguson DG; Kadambi V; Neumann JC; Doetschman T; Kranias EG
Circ Res; 1992 Nov; 71(5):1021-30. PubMed ID: 1394867
[TBL] [Abstract][Full Text] [Related]
16. Changes in cardiac mechanics with heat acclimation: adrenergic signaling and SR-Ca regulatory proteins.
Mirit E; Gross C; Hasin Y; Palmon A; Horowitz M
Am J Physiol Regul Integr Comp Physiol; 2000 Jul; 279(1):R77-85. PubMed ID: 10896867
[TBL] [Abstract][Full Text] [Related]
17. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Chu G; Luo W; Slack JP; Tilgmann C; Sweet WE; Spindler M; Saupe KW; Boivin GP; Moravec CS; Matlib MA; Grupp IL; Ingwall JS; Kranias EG
Circ Res; 1996 Dec; 79(6):1064-76. PubMed ID: 8943945
[TBL] [Abstract][Full Text] [Related]
18. Altered dose response to beta-agonists in SERCA1a-expressing hearts ex vivo and in vivo.
Huke S; Prasad V; Nieman ML; Nattamai KJ; Grupp IL; Lorenz JN; Periasamy M
Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H958-65. PubMed ID: 12181124
[TBL] [Abstract][Full Text] [Related]
19. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
20. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
Kiss E; Jakab G; Kranias EG; Edes I
Circ Res; 1994 Aug; 75(2):245-51. PubMed ID: 8033338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
